Join
Live feed
·
PRReleasevia Quantisnow
Bausch Health Companies Inc. logo

Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI® (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia

ByQuantisnow·Wall Street's wire, on your screen.
BHC· Bausch Health Companies Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BHC (Bausch Health Companies Inc.) and more on Quantisnow.